[FUNDAMENTALS AND LIMITATIONS OF ACTH AND CORTISONE TREATMENT].
D000324:Adrenocorticotropic Hormone / Q000633:toxicity*; D001167:Arteritis; D003348:Cortisone / Q000633:toxicity*; D003907:Dexamethasone; D006854:Hydrocortisone / Q000633:toxicity*; D008775:Methylprednisolone; D015434:Panniculitis; D010201:Panniculitis, Nodular Nonsuppurative; D011239:Prednisolone; D011241:Prednisone / Q000009:adverse effects*; D011618:Psychotic Disorders; D012216:Rheumatic Diseases; D014116:Toxicology; D014221:Triamcinolone
D014221:Triamcinolone; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone; D003348:Cortisone; D011241:Prednisone; D006854:Hydrocortisone; D008775:Methylprednisolone
ARTERITIS; CORTICOTROPIN TOXICOLOGY; CORTISONE TOXICOLOGY; DEXAMETHASONE; HYDROCORTISONE TOXICOLOGY; METHYLPREDNISOLONE; PANNICULITIS, NODULAR NONSUPPURATIVE; PREDNISOLONE; PREDNISONE TOXICOLOGY; PSYCHOSES; RHEUMATISM; TOXICOLOGIC REPORT; TRIAMCINOLONE
GRUNDZUEGE UND GRENZEN DER ACTH-CORTISONBEHANDLUNG.